Z-100, a polysaccharide-rich preparation extracted from the human type Mycobacterium tuberculosis, improves the resistance of Meth-A tumor-bearing mice to endogenous septic infection

Biotherapy

Volumn 10, Issue 2, 1997, Pages 139-143

  Sasaki, Hidetaka ^a,b   Kobayashi, Makiko ^a   Emori, Yutaka ^a   Ohya, Osamu ^a   Hayashi, Yoshiro ^a   Nomoto, Kikuo ^a  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Immunomodulator; Mycobacterium tuberculosis; Opportunistic infection; Suppressor cell; Z 100

Indexed keywords

ANTIBODY; ARABINOMANNAN; CD11B ANTIGEN; IMMUNOMODULATING AGENT; LYT ANTIGEN; THY 1 ANTIGEN; Z 100;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FIBROSARCOMA; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL; SUPPRESSOR CELL;

EID: 0030851753     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02678541     Document Type: Article

References (18)

1. Kuramochi S, Kameyama K, Hiraoka N, Hosoda Y, Kumai K, Ishibiki K: Evaluation of the importance of infection as cause of death in patients with malignancy: An analysis of autopsy cases. Jpn J cancer Chemother 1992; 19: 161-166
2. Roth JA: Tumor induced immunosuppression. Surg Gynecol Obstet 1983; 156: 233-240
3. Ishida N: Isolation of factors responsible for the immunosuppression found in tumor-bearing animals. Yakugaku Zasshi 1985; 105: 91-108
4. Kobatake H, Suekane T, Murakami Y, Niwa S, Okahira A, Kushida H: Studies on hot water extract of Mycobacterium tuberculosis. I. Structural analyses of polysaccharides. Yakugaku Zasshi 1981; 101: 713-722
5. Satoh H: Antitumor activity of an extract from tubercle bacilli of human type (Maruyama vaccine, or SSM) on ascites hepatomas in rats. Cancer Chemother 1978; 5: 545-548.
6. + T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type tubercle bacilli. J Natl Cancer Inst 1986; 77: 441-447
7. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F: Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis. Cancer Res 1990; 50: 4032
8. Pollard RB, Schmitt DA, Sasaki H, Hayashi Y, Suzuki F: Release of a mitogenic factor by splenic Lyt 1 + T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli. Anticancer Res 1990; 10:285-290
9. Hayashi Y, Ebina T, Suzuki F, Ishida N: Interferon inducing activity of an immunotherapeutic anticancer agent, SSM, prepared from Mycobacterium tuberculosis strain Aoyama B. Microbiol Immunol 1981; 25: 305-316
10. Ohya O, Sasaki H, Nagatani Y, Hayashi Y, Nomoto K: Therapeutic effect of SSM on hematological and immunological damage in X-ray irradiated mice. Clin Report 1990; 24: 441448
11. Sasaki H, Schmitt DA, Kobayashi M, Hayashi Y, Pollard RB, Suzuki F: Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis. Nat Immun 1993; 12: 152-167
12. Barker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331-335
13. Suzuki F, Pollard RB : Suppressor Lyt 2+ T- cells demonstrated in mice late after thermal injury. Immunol Lett 1988; 19: 33-40
14. Yokota Y: Host defense mechanism in experimentally immunocompromised animals and restorative effect of immunopotentiators. Jpn J Bacteriol 1984; 39: 29-45
15. Moss NM, Gough DB, Jordan AL, Grbic JT, Wood JJ, Rodrick ML, Mannick JA: Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 1988; 104: 882-887
16. Kupper TS, Baker CC, Ferguson TA, Green DR: A burn induced Ly-2 suppressor T cell lowers resistance to bacterial infection. J Surg Res 1985; 38: 606-612
17. Kawamura I, Mitsuyama M, Nomoto K: Enhanced protection of cyclophosphamide-treated mice against infection with Pseudomonas aeruginosa after treatment with Z-100, a polysaccharide-rich extract from Mycobacterium tuberculosis Aoyama B. Immunopharm and Immunotoxicol 1990; 12: 331-343
18. Kobayashi M, Herndon DN, Pollard RB and Suzuki F: Z100, a lipid-arabinomannan extracted from Mycobacterium tuberculosis, improves the resistance of thermally injured mice to herpes virus infections. Immunology Lett 1994; 40: 199205.